Skip to main content

Articles

Page 6 of 17

  2. Tigecycline has broad-spectrum anti-bacterial activity and often used for critically ill patients with complicated infections. Only a few clinical studies have reported the coagulation disorder induced by tige...

    Authors: Mingxing Guo, Jinwei Liang, Dandan Li, Ying Zhao, Wanyi Xu, Lei Wang and Xiangli Cui
    Citation: Thrombosis Journal 2022 20:12
    Content type: Research Published on:

  3. Vaccine-induced thrombotic thrombocytopenia (VITT) is a rare but devastating adverse event following adenoviral vector-based vaccinations for COVID-19, resulting in thrombosis, especially of the cerebral and s...

    Authors: Christy V. John, Rajesh Kumar, Anil Kumar Sivan, Sangeetha Jithin, Rojin Abraham and Chepsy C. Philip
    Citation: Thrombosis Journal 2022 20:11
    Content type: Case report Published on:

    The Correspondence to this article has been published in Thrombosis Journal 2023 21:47

  4. For patients with suspected pulmonary embolism (PE), age- or clinically-adjusted D-dimer threshold level can be used to define a negative test that safely excludes PE and reduces the use of imaging. However, t...

    Authors: Carmen Rodríguez, Luis Jara-Palomares, Eva Tabernero, Andrés Tenes, Sara González, Winnifer Briceño, José Luis Lobo, Raquel Morillo, Behnood Bikdeli and David Jiménez
    Citation: Thrombosis Journal 2022 20:10
    Content type: Research Published on:

  5. The summary of product characteristics of vaccines administered intramuscularly, including the vaccine for coronavirus SARS-CoV-2 (COVID-19) and Influenza, warned for risks of bleeding in patients treated with...

    Authors: Daniel Caldeira, Bárbara Sucena Rodrigues, Mariana Alves, Fausto J. Pinto and Joaquim J. Ferreira
    Citation: Thrombosis Journal 2022 20:9
    Content type: Research Published on:

  6. The authors have done commendable work in exploring the utility of a comprehensive viscoelastic test for assessment of the coagulation cascade in Coronavirus disease 2019 (COVID-19) patients. This article publ...

    Authors: Syed Nabeel Muzaffar, Suhail Sarwar Siddiqui, Nilanchal Chakraborty and Afzal Azim
    Citation: Thrombosis Journal 2022 20:8
    Content type: Correspondence Published on:

  8. Administration of recombinant human soluble thrombomodulin (rTM) is often used in Japan to treat septic disseminated intravascular coagulation (DIC). Thrombin-activatable fibrinolysis inhibitor (TAFI) is a fib...

    Authors: Takaaki Totoki, Takashi Ito, Midori Kakuuchi, Nozomi Yashima, Ikuro Maruyama and Yasuyuki Kakihana
    Citation: Thrombosis Journal 2022 20:6
    Content type: Case Report Published on:

  10. Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is triggered by nCOV-19 adenovirus-vectored vaccines against SARS-CoV2. Pathogenesis has been mainly related to platelet activation via PF4-reactiv...

    Authors: Lasse Myllylahti, Hanna Pitkänen, Harry Magnani and Riitta Lassila
    Citation: Thrombosis Journal 2022 20:4
    Content type: Research Published on:

  11. Continuous agitation during storage slows down the platelet storage lesions. However, in special circumstances, manual-mixing can be alternatively used to store products for short time periods without compromi...

    Authors: Ehteramolsadat Hosseini, Amin Solouki, Masood Haghshenas, Mehran Ghasemzadeh and Simone M. Schoenwaelder
    Citation: Thrombosis Journal 2022 20:3
    Content type: Research Published on:

    The Correction to this article has been published in Thrombosis Journal 2022 20:16

  13. Growing evidence suggests the relationship between obstructive sleep apnea (OSA) and venous thromboembolism (VTE). Few studies focused on VTE recurrence risk associated with OSA after anticoagulation cessation.

    Authors: Olivier Nepveu, Charles Orione, Cécile Tromeur, Alexandre Fauché, Cecile L’heveder, Marie Guegan, Catherine Lemarié, David Jimenez, Christophe Leroyer, Karine Lacut, Francis Couturaud and Raphael Le Mao
    Citation: Thrombosis Journal 2022 20:1
    Content type: Research Published on:

  15. Antithrombin deficiency (ATD) is an autosomal dominant thrombophilia presenting with varying phenotypes. In pediatric patients with ATD, thrombosis typically develops during the neonatal period or adolescence....

    Authors: M. Müller-Knapp, C. F. Classen, R. Knöfler, C. Spang, C. Hauenstein, T. Heinrich, F. L. P. Gabriel, J. Däbritz, D. A. Reuter and J. Ehler
    Citation: Thrombosis Journal 2021 19:105
    Content type: Case report Published on:

  17. Antiphospholipid Syndrome (APS) is a multisystemic autoimmune disease characterized by arterial and venous thrombosis and / or obstetric morbidity in the presence of at least one circulating anti-phospholipid ...

    Authors: Vanda Pinto, Augusto Ministro, Nuno Reis Carreira, Ana Cardoso, Catarina Sousa Gonçalves, Mickael Henriques, João Rato, Emanuel Silva and Luís Mendes Pedro
    Citation: Thrombosis Journal 2021 19:103
    Content type: Case report Published on:

  18. Data on the prognostic role of D-dimer in patients with acute coronary syndrome (ACS) are controversial. Our aim was to summarize current evidence on the association between D-dimer levels and short/long-term ...

    Authors: Flavio Giuseppe Biccirè, Alessio Farcomeni, Carlo Gaudio, Pasquale Pignatelli, Gaetano Tanzilli and Daniele Pastori
    Citation: Thrombosis Journal 2021 19:102
    Content type: Research Published on:

    The Correction to this article has been published in Thrombosis Journal 2022 20:7

  19. To our knowledge, the treatment, outcome, clinical presentation, risk stratification of patients with venous thromboembolism and COVID-19 have not been well characterized.

    Authors: Mauricio Castillo-Perez, Carlos Jerjes-Sanchez, Alejandra Castro-Varela, Jose Gildardo Paredes-Vazquez, Eduardo Vazquez-Garza, Ray Erick Ramos-Cazares, Jose Alfredo Salinas-Casanova, Abigail Montserrat Molina-Rodriguez, Arturo Adrián Martinez-Ibarra, Mario Alejandro Fabiani, Yoezer Z Flores-Sayavedra, Jaime Alberto Guajardo-Lozano, Hector Lopez-de la Garza, Hector Betancourt-del Campo, Daniela Martinez-Magallanes and Jathniel Panneflek
    Citation: Thrombosis Journal 2021 19:101
    Content type: Research Published on:

  20. The choice of optimal antithrombotic therapy in atrial fibrillation (AF) patients with acute coronary syndrome (ACS) or percutaneous coronary intervention (PCI) remains controversial. The aim of this longitudi...

    Authors: Chiao-Chin Lee, Chiao-Hsiang Chang, Yuan Hung, Chin-Sheng Lin, Shih-Ping Yang, Shu-Meng Cheng, Fan-Han Yu, Wei-Shiang Lin and Wen-Yu Lin
    Citation: Thrombosis Journal 2021 19:100
    Content type: Research Published on:

  21. To evaluate the anticoagulant treatment response in venous thrombi with different morphologies (size, shape, and echogenicity) by measuring the change in thrombus thickness.

    Authors: Tanapong Panpikoon, Wisanu Phattharaprueksa, Tharintorn Treesit, Chinnarat Bua-ngam, Kaewpitcha Pichitpichatkul and Apichaya Sriprachyakul
    Citation: Thrombosis Journal 2021 19:99
    Content type: Research Published on:

  22. Long-term oral anticoagulant should be considered or recommended in patients with atrial fibrillation (AF) and CHA2DS2VASc score ≥ 1 for stroke prevention. Warfarin and different direct oral anticoagulants (DO...

    Authors: Wei-Chieh Lee, Pai-Wei Lee, Po-Jui Wu, Yen-Nan Fang, Huang-Chung Chen, Yu-Sheng Lin, Hsiu-Yu Fang, Shang-Hung Chang, Ping-Yen Liu and Mien-Cheng Chen
    Citation: Thrombosis Journal 2021 19:98
    Content type: Research Published on:

    The Correction to this article has been published in Thrombosis Journal 2021 19:106

  23. Knowledge on the pharmacodynamic effects of antiplatelet drugs including clopidogrel and ticagrelor on Asian patients is scarce. We aim to evaluate the effects of the two drugs on platelet reactivity in the tr...

    Authors: Yang Zhang, Rui Peng, Xiaojuan Li, Gaowa Cheng, Ximing Wang, Jinxing Yu, Muxing Hua, Xi Chen and Zhou Zhou
    Citation: Thrombosis Journal 2021 19:97
    Content type: Research Published on:

  24. Acute limb ischemia (ALI) is an important clinical event threatening both life and the affected limbs, but the optimal treatment for ALI remains undefined. The aim of this study was to compare the safety and e...

    Authors: Maofeng Gong, Xu He, Boxiang Zhao, Jie Kong, Jianping Gu and Guoping Chen
    Citation: Thrombosis Journal 2021 19:96
    Content type: Research Published on:

  25. Cancer-associated venous thromboembolism (VTE) is common in patients with primary lung cancer. It has been understudied which authoritative risk assessment score of cancer-associated VTE is optimal for the ass...

    Authors: Wei Xiong, Yunfeng Zhao, He Du, Yanmin Wang, Mei Xu and Xuejun Guo
    Citation: Thrombosis Journal 2021 19:95
    Content type: Research Published on:

  26. Type 3 von Willebrand disease (VWD) exhibits severe hemorrhagic tendency with complicated pathogenesis. The C-terminal cystine knot (CTCK) domain plays an important role in the dimerization and secretion of vo...

    Authors: Yuxin Zhang, Fengwu Chen, Aizhen Yang, Xiaoying Wang, Yue Han, Depei Wu, Yi Wu and Jingyu Zhang
    Citation: Thrombosis Journal 2021 19:94
    Content type: Research Published on:

  28. Immune-mediated necrotizing myopathy (IMNM) is characterized by proximal muscle weakness, elvated serum muscle enzyme levels, myopathic electromyography findings, and necrotic muscle fiber with few inflammator...

    Authors: Jiali Li, Mingming Yan, Jiao Qin, Lingyan He, Cao Dai and Rui Wen
    Citation: Thrombosis Journal 2021 19:92
    Content type: Case report Published on:

  29. Anticoagulation in hospitalized COVID-19 patients has been associated with survival benefit; however, the optimal anticoagulant strategy has not yet been defined. The objective of this meta-analysis was to inv...

    Authors: Sirui Zhang, Yupei Li, Guina Liu and Baihai Su
    Citation: Thrombosis Journal 2021 19:91
    Content type: Research Published on:

  30. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is considered to have multiple roles in the development of atherosclerosis, which is recently reported to participate in the thrombotic process. We aimed t...

    Authors: Jia Peng, Ming-Ming Liu, Hui-Hui Liu, Yuan-Lin Guo, Na-Qiong Wu, Qian Dong, Jie Qian, Ke-Fei Dou, Cheng-Gang Zhu and Jian-Jun Li
    Citation: Thrombosis Journal 2021 19:90
    Content type: Research Published on:

  31. Post-operative atrial fibrillation (POAF) is the most common complication after cardiac surgery. Recent studies had shown this phenomenon is no longer considered transitory and is associated with higher risk o...

    Authors: Mariana Fragão-Marques, Francisco Teixeira, Jennifer Mancio, Nair Seixas, João Rocha-Neves, Inês Falcão-Pires and Adelino Leite-Moreira
    Citation: Thrombosis Journal 2021 19:89
    Content type: Review Published on:

  32. Rupture of an atherosclerotic plaque and subsequent exposure of the subendothelial prothrombotic matrix to blood cause arterial thrombosis. Circulating platelets play an indispensable role in the growth of art...

    Authors: Yuu Oda, Takashi Ito, Yoichiro Yamada, Tadashi Koga, Tomoka Nagasato, Tomoko Ohnishi-Wada, Kazuya Hosokawa, Hiroyuki Fukase, Teruto Hashiguchi and Ikuro Maruyama
    Citation: Thrombosis Journal 2021 19:88
    Content type: Research Published on:

  33. The prevalence of venous thromboembolism (VTE) is high in critically ill patients with COVID-19. Dosing of Low Molecular Weight Heparin (LMWH) for thromboprophylaxis in patients with severe COVID-19 is subject...

    Authors: David Oliver Hamilton, Alexander Main-Ian, Jessie Tebbutt, Maya Thrasher, Alicia Waite and Ingeborg Welters
    Citation: Thrombosis Journal 2021 19:87
    Content type: Letter to the Editor Published on:

  34. Thromboembolic and bleeding events after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are major public concerns leading to vaccine hesitancy. Due to low incidence, an indivi...

    Authors: Noppacharn Uaprasert, Krissana Panrong, Ponlapat Rojnuckarin and Thita Chiasakul
    Citation: Thrombosis Journal 2021 19:86
    Content type: Research Published on:

  35. The present study aimed to explore these characteristics, particularly thin-cap fibroatheroma (TCFA), in relation to residual syntax score (rSS) in patients who presented with acute MI.

    Authors: Xiaoxiao Zhao, Ying Wang, Runzhen Chen, Jiannan Li, Jinying Zhou, Chen Liu, Peng Zhou, Zhaoxue Sheng, Yi Chen, Li Song, Hanjun Zhao and Hongbing Yan
    Citation: Thrombosis Journal 2021 19:85
    Content type: Research Published on:

  36. Superior Vena Cava (SVC) syndrome, is a quite rare but serious complication after pacemaker lead implantation; most patients are asymptomatic due to the development of adequate venous collateral circulation.

    Authors: Nicola Mumoli, Antonino Mazzone, Isabella Evangelista, Marco Cei and Alessandra Colombo
    Citation: Thrombosis Journal 2021 19:84
    Content type: Case report Published on:

  37. Few studies detail the evolution of COVID-19 associated coagulopathy. We performed serial thromboelastography (TEG) and laboratory coagulation studies in 40 critically-ill, mechanically ventilated COVID-19 pat...

    Authors: Colette Neethling, Gregory Calligaro, Malcolm Miller and Jessica J. S. Opie
    Citation: Thrombosis Journal 2021 19:83
    Content type: Research Published on:

  38. Timely diagnosis of disseminated intravascular coagulation (DIC) in hemophagocytic lymphohistiocytosis (HLH) patients is crucial but challenging, as HLH interferes with the results of the laboratory tests incl...

    Authors: Liqin Ling, Xunbei Huang, Chaonan Liu, Juan Liao and Jing Zhou
    Citation: Thrombosis Journal 2021 19:82
    Content type: Case report Published on:

  39. Cerebral venous sinus thrombosis (CVST) is a relatively rare, but potentially lethal condition. In approximately 15% of the patients, the cause of CVST remains unclear. Conventional clotting tests such as prot...

    Authors: Myrthe M. van der Bruggen, Bram Kremers, Rene van Oerle, Robert J. van Oostenbrugge and Hugo ten Cate
    Citation: Thrombosis Journal 2021 19:81
    Content type: Research Published on:

  41. COVID-19 infection is associated with a hypercoagulable state. Severe COVID-19 patients present with high plasma fibrinogen levels, continuous deposition of fibrin and the presence of microthrombi in their lun...

    Authors: Yael Lichter, Tanya Badelbayov, Irina Shalev, Reut Schvartz, Yishay Szekely, Dan Benisty, Ilana Goldiner, Maxim Kagarlyk, Keren Asraf, Ram Doolman, Efrat Luttwak, Ilya Kirgner, Irit Avivi, Nimrod Adi and Ben-Zion Katz
    Citation: Thrombosis Journal 2021 19:79
    Content type: Research Published on:

  42. The severity of pulmonary arterial hypertension (PAH) is classified based on mean pulmonary artery pressure (mPAP) levels. However, other markers have not been elucidated. Fibrinolytic markers, such as total p...

    Authors: Makoto Shoji, Taiju Matsui, Hideaki Tanaka, Kosuke Nomura, Hiroaki Tsujita, Yusuke Kodama, Shinji Koba, Youichi Kobayashi and Toshiro Shinke
    Citation: Thrombosis Journal 2021 19:78
    Content type: Research Published on:

  43. This study aimed to investigate the background of patients who presented with pulmonary embolism (PE) on contrast-enhanced chest computed tomography (CT) and to explore the risk factors for PE.

    Authors: Kaoru Fujieda, Akiko Nozue, Akie Watanabe, Keiko Shi, Hiroya Itagaki, Yoshihiko Hosokawa, Keiko Nishida, Nobutaka Tasaka, Toyomi Satoh and Ken Nishide
    Citation: Thrombosis Journal 2021 19:77
    Content type: Research Published on:

  44. Venous thromboembolism (VTE) is a common complication among patients with cancer and is one of the most common causes of increased morbidity and mortality. The use of direct oral anticoagulants (DOACs) for thr...

    Authors: Norah S. Alsubaie, Shahad M. Al Rammah, Reema A. Alshouimi, Mohammed Y. Alzahrani, Majed S. Al Yami, Abdulaali R. Almutairi, Osamah M. Alfayez, Ghazwa B. Korayem and Omar A. Almohammed
    Citation: Thrombosis Journal 2021 19:76
    Content type: Research Published on:

  45. In the recent COVID19 pandemic, patients with hematological disorders were considered at high risk for severe disease. Limited data is available regarding the course of COVID19 infection in this subgroup.

    Authors: Sufana Shikdar, Azra Borogovac, Elabdallah Mohamad and Mohamad Khawandanah
    Citation: Thrombosis Journal 2021 19:75
    Content type: Case report Published on:

  46. Activated protein C resistance (APCR) due to factor V Leiden (FVL) mutation (R506Q) is a major risk factor in patients with venous thromboembolism (VTE). The present study investigated the clinical manifestati...

    Authors: Vahideh Takhviji, Kazem Zibara, Asma Maleki, Ebrahim Azizi, Sanaz Hommayoun, Mohammadreza Tabatabaei, Seyed Esmaeil Ahmadi, Maral Soleymani, Omid Kiani Ghalesardi, Mina Farokhian, Afshin Davari, Pouria Paridar, Anahita Kalantari and Abbas Khosravi
    Citation: Thrombosis Journal 2021 19:74
    Content type: Research Published on:

  47. This study was aimed to determine how platelet reactivity (PR) on dual antiplatelet therapy predicts ischemic and bleeding events in patients underwent percutaneous coronary intervention (PCI).

    Authors: Jing Wang, Jing Wang, Zhou Dong, Jiazheng Ma, Jianzhen Teng, Tong Wang, Xiaofeng Zhang, Qian Gu, Zekang Ye, Inam Ullah, Chuchu Tan, Samee Abdus, Lu Shi, Xiaoxuan Gong and Chunjian Li
    Citation: Thrombosis Journal 2021 19:73
    Content type: Research Published on:

  48. The antithrombotic effect of vitamin K antagonists (VKA) depends on controlled lowering of the activity of factors (F) II and X whereas reductions in FVII and FIX play little role. PT-INR based monitoring, how...

    Authors: Pall T. Onundarson, Ragnar Palsson, Daniel M. Witt and Brynja R. Gudmundsdottir
    Citation: Thrombosis Journal 2021 19:72
    Content type: Review Published on:

  50. Coagulopathy and following massive bleeding are complications of cardiovascular surgery, particularly occurring after procedures requiring prolonged cardiopulmonary bypass (CPB). Reliable and rapid tests for c...

    Authors: Yoshie Kawahara, Kohei Ohtsuka, Kimine Tanaka, Mayumi Yamanaka, Hiroyuki Kamiya, Takayuki Kunisawa and Satoshi Fujii
    Citation: Thrombosis Journal 2021 19:70
    Content type: Research Published on:
Submit manuscript

Official journal of

  • APSTH logo

  • Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.

Follow

Annual Journal Metrics

  • 2022 Citation Impact
    3.1 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.011 - SNIP (Source Normalized Impact per Paper)
    0.699 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    107 days submission to accept (Median)

    2023 Usage 
    708,004 downloads
    943 Altmetric mentions 

Thrombosis Journal

ISSN: 1477-9560

Contact us